People · Operator
Named in public records as an officer, director or promoter · active 2012–2021 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tendyne Holdings, Inc. | — | Biotechnology | Series B | $67.5M | $992.2M | 2012 |
| Vascudyne, Inc. | — | Other Technology | Series B | $19.6M | $346.3M | 2021 |
Kemal Schankereli at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kemal Schankereli on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Martin J. Waters | 1 | 9 |
| Joseph M. Smith | 1 | 3 |
| Greg Pearl | 1 | 2 |
| Edward W. Malouf | 1 | 2 |
| Jeffrey Franco | 1 | 2 |
| Kemal W. Schankereli | 1 | 1 |
| Greg W. Pearl | 1 | 1 |
| Edward Mercaldo | 1 | 1 |
| Claude Amos | 1 | 1 |
| David W. McIntyre | 1 | 1 |
| Jim D. Ness | 1 | 1 |
| Kemal D. Schakereli | 1 | 1 |
| Jeffrey D. Franco | 1 | 1 |
| Joseph W. Smith | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.